New Efficacy Results on the use of Cicaplast Baume B5+ in intimate areas irritation management

  • 5min
  • Jan. 2025
  • Supported by
  • La Roche-Posay
Proper hygiene and care are essential for preventing skin issues like vulvitis, balanitis, and diaper dermatitis by maintaining the skin’s natural barrier, minimizing exposure to irritants, and reducing the risk of infections.
Cicaplast Baume B5+ has been tested in real-life practice in vulvitis, balanitis and non-oozing diaper dermatitis. The results below scale-up Cicaplast Baume B5+ as a new standard of care in managing intimate areas irritation.

Cicaplast Baume B5+ Improves vulvitis & balanitis global severity signs.

Cicaplast Baume B5+


Cicaplast Baume B5+ boosts vulvitis and balanitis patients’ quality of life.

Cicaplast Baume B5+

REFERENCE:
1. New Observational study, Cicaplast Baume B5+, 185 patients with vulvitis & balanitis, at least once per day as prescribed by the Dermatologists


Cicaplast Baume B5+ boosts diapêr dermatitis patients’ quality of life.

Cicaplast Baume B5+

REFERENCE:
2. Observational study, Cicaplast Baume B5+, 399 patients with non-oozing diaper dermatitis, at least once per day as prescribed by the Dermatologists


Cicaplast Baume B5+ high to excellent tolerability rates assessed by doctors and patients.

Cicaplast Baume B5+

REFERENCE:
3. Observational study, Cicaplast Baume B5+, 584 patients with vulvitis, balanitis & non-oozing diaper dermatitis, at least once per day as prescribed by the Dermatologists